Table I.
History of vaccination of finishing pigs against Porcine circovirus type 2 (PCV2) and blood sample collection on 7 farms
| Farm | Number of pigs | Vaccinea and age at vaccination (wk) | Age at sampling (wk) | Mean body weight of group (kg)
|
|
|---|---|---|---|---|---|
| Light | Heavy | ||||
| A | 440 | BI (6) | 21 | 73 | 109 |
| B | 420 | IV (3 & 5) | 20 | 73 | 109 |
| C | 450 | IV (3 & 5) | 22–23 | 71 | 105 |
| D | 480 | IV (3 & 5) | 23 | 75 | 109 |
| E | 500 | BI (4) | 22 | 73 | 118 |
| F | 380 | BI (3) | 22 | 95 | 122 |
| G | 350 | IV (3 & 5) | 23 | 80 | 120 |
a
BI — Ingelvac CircoFLEX, Boehringer Ingelheim Vetmedica, St. Joseph, Missouri, USA; 1 dose of 1.0 mL. IV — Circumvent PCV, Intervet/Schering–Plough Animal Health, Summit, New Jersey, USA; 2 doses of 2.0 mL.